Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 23rd:

Bio-Techne Corporation (TECH Quick QuoteTECH - Free Report) : This manufacturer of biotechnology reagents has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 0.5% over the last 60 days.

Bio-Techne’s shares gained 9.9% over the last one month more than S&P 500’s gain of 5.6%. The company possesses a Momentum Score of A.

UnitedHealth Group Incorporated (UNH Quick QuoteUNH - Free Report) : This diversified health company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 14.3% over the last 60 days.

UnitedHealth Group’s shares gained 10.7% over the last one month. The company possesses a Momentum Score of A.

Fibrocell Science, Inc. : This gene therapy company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 36.8% over the last 60 days.

Fibrocell Science’s shares gained 14.5% over the last one month. The company possesses a Momentum Score of B.

Boot Barn Holdings, Inc. (BOOT Quick QuoteBOOT - Free Report) : This lifestyle retail chain operator has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 13.6% over the last 60 days.

Boot Barn Holdings’ shares gained 9.1% over the last one month. The company possesses a Momentum Score of A.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>